As of April 29, 2025, Spruce Biosciences (SPRB) has a market cap of $3.317 million USD. According to our data, Spruce Biosciences is ranked No.9096 in global market value.
Year | Market Cap | %Change |
---|---|---|
Apr 29, 2025 | $3.32 M |
-80.88%
|
Dec 31, 2024 | $17.35 M |
-85.67%
|
Dec 29, 2023 | $0.12 B |
167.09%
|
Dec 30, 2022 | $45.31 M |
-75.40%
|
Dec 31, 2021 | $0.18 B |
-81.65%
|
Dec 31, 2020 | $1.00 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() Neurocrine Biosciences
NBIX
|
$10.61 B |
-0.000 M
|
![]() USA
|
![]() Ultragenyx
RARE
|
$3.57 B |
0.000 M
|
![]() USA
|
![]() Ascendis Pharma
ASND
|
$10.02 B |
0.000 M
|
![]() Denmark
|
![]() BioMarin Pharmaceutical
BMRN
|
$12.13 B |
0.000 M
|
![]() USA
|
![]() Rhythm Pharmaceuticals
RYTM
|
$4.12 B |
0.000 M
|
![]() USA
|
![]() Crinetics Pharmaceuticals
CRNX
|
$3.12 B |
-0.000 M
|
![]() USA
|
![]() Corcept Therapeutics
CORT
|
$7.77 B |
-0.000 M
|
![]() USA
|
![]() Xeris Pharmaceuticals
XERS
|
$0.69 B |
0.000 M
|
![]() USA
|
![]() Soleno Therapeutics
SLNO
|
$3.76 B |
-0.000 M
|
![]() USA
|
Market Cap | = | SPRB Stock Price | * | SPRB Shares Outstanding |
= | $0.08 | * | 42.20 M | |
= | $3.32 M |